C, P., V, M., A, J., H, Y., R, A., I, K., & N, D. (2014). Multicenter experience of nonpegylated liposomal doxorubicin use in the management of metastatic breast cancer. Clinical breast cancer, 14(2), 85. https://doi.org/10.1016/j.clbc.2013.10.011
Chicago Style (17th ed.) CitationC, Palmieri, Misra V, Januszewski A, Yosef H, Ashford R, Keary I, and Davidson N. "Multicenter Experience of Nonpegylated Liposomal Doxorubicin Use in the Management of Metastatic Breast Cancer." Clinical Breast Cancer 14, no. 2 (2014): 85. https://doi.org/10.1016/j.clbc.2013.10.011.
MLA (9th ed.) CitationC, Palmieri, et al. "Multicenter Experience of Nonpegylated Liposomal Doxorubicin Use in the Management of Metastatic Breast Cancer." Clinical Breast Cancer, vol. 14, no. 2, 2014, p. 85, https://doi.org/10.1016/j.clbc.2013.10.011.